Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Cazzola

Showing results (141-150 of 802) with videos related to

Pageof 81
Sort By:
Journal of Thoracic Disease|August 31, 2013
The role of indacaterol for chronic obstructive pulmonary disease (COPD)Mario Cazzola, Floriana Bardaro, Emanuele Stirpe
Expert Review of Respiratory Medicine|December 9, 2014
Fluticasone furoate and vilanterol inhalation powder for the treatment of chronic obstructive pulmonary diseaseMaria Gabriella Matera, Annalisa Capuano, Mario Cazzola
Expert Opinion on Pharmacotherapy|November 25, 2014
Indacaterol for the treatment of chronic obstructive pulmonary diseaseMaria Gabriella Matera, Paola Rogliani, Mario Cazzola
The Lancet. Respiratory Medicine|July 26, 2015
Cardiovascular disease in patients with COPDMario Cazzola, Paola Rogliani, Maria Gabriella Matera
Allergy|February 9, 2021
Long-acting muscarinic antagonists and small airways in asthma: Which link?Mario Cazzola, Luigino Calzetta, Maria Gabriella Matera
European Journal of Pharmacology|May 19, 2015
Pharmacological interaction between LABAs and LAMAs in the airways: optimizing synergyLuigino Calzetta, Maria Gabriella Matera, Mario Cazzola
Archivos De Bronconeumologia|March 7, 2022
The Future of Bronchodilators in COPD and AsthmaMario Cazzola, Paola Rogliani, Maria Gabriella Matera
Clinical Pharmacokinetics|February 5, 2002
Clinical pharmacokinetics of salmeterolMario Cazzola, Renato Testi, Maria Gabriella Matera
British Journal of Pharmacology|January 15, 2011
β(2) -adrenoceptor agonists: current and future directionMario Cazzola, Luigino Calzetta, Maria Gabriella Matera
Respiration; International Review of Thoracic Diseases|April 13, 2005
Inflammation--a new therapeutic target in pneumoniaMario Cazzola, Maria Gabriella Matera, Gabriella Pezzuto
Pageof 81

Showing results (141-150 of 802) with videos related to

Sort By:
Pageof 81
Journal of Thoracic Disease|August 31, 2013
The role of indacaterol for chronic obstructive pulmonary disease (COPD)Mario Cazzola, Floriana Bardaro, Emanuele Stirpe
Expert Review of Respiratory Medicine|December 9, 2014
Fluticasone furoate and vilanterol inhalation powder for the treatment of chronic obstructive pulmonary diseaseMaria Gabriella Matera, Annalisa Capuano, Mario Cazzola
Expert Opinion on Pharmacotherapy|November 25, 2014
Indacaterol for the treatment of chronic obstructive pulmonary diseaseMaria Gabriella Matera, Paola Rogliani, Mario Cazzola
The Lancet. Respiratory Medicine|July 26, 2015
Cardiovascular disease in patients with COPDMario Cazzola, Paola Rogliani, Maria Gabriella Matera
Allergy|February 9, 2021
Long-acting muscarinic antagonists and small airways in asthma: Which link?Mario Cazzola, Luigino Calzetta, Maria Gabriella Matera
European Journal of Pharmacology|May 19, 2015
Pharmacological interaction between LABAs and LAMAs in the airways: optimizing synergyLuigino Calzetta, Maria Gabriella Matera, Mario Cazzola
Archivos De Bronconeumologia|March 7, 2022
The Future of Bronchodilators in COPD and AsthmaMario Cazzola, Paola Rogliani, Maria Gabriella Matera
Clinical Pharmacokinetics|February 5, 2002
Clinical pharmacokinetics of salmeterolMario Cazzola, Renato Testi, Maria Gabriella Matera
British Journal of Pharmacology|January 15, 2011
β(2) -adrenoceptor agonists: current and future directionMario Cazzola, Luigino Calzetta, Maria Gabriella Matera
Respiration; International Review of Thoracic Diseases|April 13, 2005
Inflammation--a new therapeutic target in pneumoniaMario Cazzola, Maria Gabriella Matera, Gabriella Pezzuto
Pageof 81